Skip to main
DXCM

DexCom (DXCM) Stock Forecast & Price Target

DexCom (DXCM) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 48%
Buy 38%
Hold 10%
Sell 5%
Strong Sell 0%

Bulls say

DexCom is expected to have several upside drivers in the future, including the 15-day rollout and international Stelo for automatic insulin delivery, as well as potential coverage of T2NIT by CMS in the US. With strong 1Q26 performance and bullish expectations for the future, the company remains positioned for growth and positive financials despite recent controversy and market fluctuations.

Bears say

DexCom is experiencing slowing growth in the US market, while also facing stiff competition from leading competitor Abbott Laboratories. Additionally, there are concerns about DexCom's ability to secure coverage for its CGM systems from insurance providers, which could impact future revenue. Despite the company's strong momentum in international markets and expansion into integration with insulin pumps, there is still a level of uncertainty surrounding DexCom's ability to continue its growth trajectory.

DexCom (DXCM) has been analyzed by 21 analysts, with a consensus rating of Buy. 48% of analysts recommend a Strong Buy, 38% recommend Buy, 10% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DexCom and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DexCom (DXCM) Forecast

Analysts have given DexCom (DXCM) a Buy based on their latest research and market trends.

According to 21 analysts, DexCom (DXCM) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $84.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $84.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DexCom (DXCM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.